ArticleMolecules (Basel, Switzerland)2024
Novel Iridoid Derivatives Isolated from the Roots of
Ziran Li, Yang Xu, Xu Sun, Zhangrui Fan, Ziling Zhou, Fucai Ren, Ning Li, Lei Di
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Ziran LiAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Yang XuAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Xu SunAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Zhangrui FanAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Ziling ZhouAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Fucai RenAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.ORCID 0000-0002-8685-9283 Ning LiAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.ORCID 0000-0002-2650-363X Lei DiAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.ORCID 0000-0003-1870-4850 Funding
Grants for Scientific Research of BSKY from Anhui Medical University 0601055101Natural Science Research Project of the Anhui Educational Committee KJ2020A0156
6 · The paper itselfAbstract
Scabrol B and Scabrol C, two newly identified iridoid derivatives (
Indexed as
FibrosisIridoidsPatriniaPlant RootsAnimalsCell LineKidneyKidney DiseasesMolecular StructurePlant ExtractsRatsTransforming Growth Factor beta1IridoidsPlant ExtractsTransforming Growth Factor beta1iridoid derivativesisovaleratePatrinia scabra Bungerenal fibrosis
Identifiers
PMID39339414
PMCPMC11433686
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390